| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |